Skip to content

Clinical Database Associated With a Biological Banking Accessible to Initiate Epidemiological and Translational Collaborative Researches in Kidney Transplantation

The French DIVAT: a Clinical Database Associated With a Biological Banking Accessible to Initiate Epidemiological and Translational Collaborative Researches in Kidney Transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02900040
Acronym
DIVAT
Enrollment
30000
Registered
2016-09-14
Start date
1994-01-31
Completion date
2050-01-31
Last updated
2016-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplantation

Brief summary

The French DIVAT (standing for Données Informatisées et VAlidées en Transplantation in french, and in English Computerized and VAlidated Data in Transplantation ) cohort was Kicked off in 1994 by the Transplantation Urology Nephrology Institute of the Nantes University Hospital in France. The primary objective of this multicenter computerized database was to enable prospective clinical and epidemiological research studies concerning kidney transplant recipients, particularly focusing on mid- and long-term clinical outcomes, therapeutic strategies and public health issues. The patient-case system of the DIVAT cohort allows the monitoring of medical records of all patient-specific and allograft-specific data, including bio-banking since 2005. Data are collected from the date of transplantation until the graft failure, at each scheduled outpatient visit or hospital admission motivating by a new clinical, therapeutical or biological expression. The DIVAT cohort contains information on more than 11000 transplant recipients between 1994 and today, issued from 8 French university hospitals centers (the DIVAT Network is organized by a consortium agreement). 18% of all patients underwent retransplantation and 11% of all kidney transplants originated from living donors. The DIVAT network heavily works to ensure a high-quality data collection with the aim of exploring adequately the complex post-transplantation process. The Divat network encourage collaborations and enables interested researchers to submit a research project by completing a request form available on the DIVAT website (http://www.divat.fr/en) describing the context, objectives and design of the study

Interventions

OTHERkidney transplantation

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* over the age of 18 years * with renal transplant

Exclusion criteria

* minor * pediatric transplantation

Design outcomes

Primary

MeasureTime frame
Proportion of participants with Overall Survival2 years

Secondary

MeasureTime frameDescription
expansion of effector memory CD8+ T cells dosage1 yearpotential marker for acute graft dysfunction

Countries

France

Contacts

Primary ContactMagali Giral, PU-PH
mgiral@chu-nantes.fr+33 (0)2 40 08 74 43

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026